In the article by Markantes et al. entitled “Therapeutic Equivalence of a New Preparation of Liquid Levothyroxine with Tablets in Patients with Overt Primary Hypothyroidism” [Eur Thyroid J, DOI: 10.1159/000508216], the Disclosure Statement did not mention the conflicts of interest of Mrs. Ioulia Tseti. It should read as follows:
Mrs. Ioulia Tseti is the CEO of Uni-Pharma S.A., Athens, Greece. All other authors do not have any conflicts of interest to declare.
European Thyroid Journal is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
As an open-access journal, European Thyroid Journal articles are immediately available to read on publication, without restriction. The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Jan 2022 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 342 | 138 | 40 |
| PDF Downloads | 178 | 54 | 5 |
Online ISSN: 2235-0802
Print ISSN: 2235-0640
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519
